# Addition of Probenecid to Penicillin-V Therapy

> **NCT05082909** · PHASE1,PHASE2 · COMPLETED · sponsor: **Imperial College London** · enrollment: 21 (actual)

## Conditions studied

- Infection, Bacterial

## Interventions

- **DRUG:** Probenecid

## Key facts

- **NCT ID:** NCT05082909
- **Lead sponsor:** Imperial College London
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-12-21
- **Primary completion:** 2022-07-07
- **Final completion:** 2022-07-07
- **Target enrollment:** 21 (ACTUAL)
- **Last updated:** 2025-01-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05082909

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05082909, "Addition of Probenecid to Penicillin-V Therapy". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT05082909. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*